Janina Markowska
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 37
- Endometriosis Research and Treatment 13
- Obstetrics and Gynecology top 5%
- Endometrial and Cervical Cancer Treatments 19
- Uterine Myomas and Treatments 7
- Cancer Research top 10%
- Oncology top 10%
- Cancer Cells and Metastasis 7
- Pathology and Forensic Medicine top 10%
-
- Cervical Cancer and HPV Research 18
-
- Cancer Research and Treatments 8
-
- Intraperitoneal and Appendiceal Malignancies 7
Janina Markowska
126 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 103
- Reproductive Medicine 323
- Obstetrics and Gynecology 172
- Cancer Research 246
- Oncology 370
- Pathology and Forensic Medicine 145
Countries citing papers authored by Janina Markowska
This map shows the geographic impact of Janina Markowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janina Markowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janina Markowska more than expected).
Fields of papers citing papers by Janina Markowska
This network shows the impact of papers produced by Janina Markowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janina Markowska. The network helps show where Janina Markowska may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Janina Markowska, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 7 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 16 | |
| 6 | 2023 | 7 | |
| 7 | 2022 | 22 | |
| 8 | 2022 | 21 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 24 | |
| 11 | 2020 | 24 | |
| 12 | 2020 | 11 | |
| 13 | 2019 | 7 | |
| 14 | 2019 | 2 | |
| 15 | 2017 | 65 | |
| 16 | Salinomycyna – przełom w leczeniu raka jajnika? | 2016 | 1 |
| 17 | Nosicielstwo mutacji w eksonie 6 genu NBS1 a ryzyko zachorowania na mięśniaki macicy | 2011 | 1 |
| 18 | Oncology and infertility: selected issues. Part II. Preservation of the reproductive function | 2005 | 1 |
| 19 | Brain metastases in patients with breast cancer | 2004 | 0 |
| 20 | Retrospective appraisal of intensity of skin postradiation reactions in breast cancer patients treated with telegammatherapy. | 1994 | 2 |
About Janina Markowska
Janina Markowska is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Cancer Research, having authored 134 papers that have together received 1.3k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (37 papers), Endometrial and Cervical Cancer Treatments (19 papers), Cervical Cancer and HPV Research (18 papers), Endometriosis Research and Treatment (13 papers), Cancer Research and Treatments (8 papers), Cancer Cells and Metastasis (7 papers), Intraperitoneal and Appendiceal Malignancies (7 papers) and Uterine Myomas and Treatments (7 papers). The work is most often cited by research in Reproductive Medicine (323 citations), Obstetrics and Gynecology (172 citations) and Cancer Research (246 citations). Janina Markowska has collaborated with scholars based in Poland, Germany and Italy. Frequent co-authors include Anna Markowska, Adam Huczyński, Michał Antoszczak, Stefan Sajdak, PAWEŁ JAŁOSZYŃSKI, Maciej Kujawski, Krzysztof Szyfter, Radosław Mądry, Zbigniew Kojs and A Harłozińska. Their work appears in journals such as Nutrients, Advances in Clinical and Experimental Medicine, Cancers, The International Journal of Biological Markers and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.